AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 275: G979-G983, 1998;
0193-1857/98 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Foxx-Orenstein, A. E.
Right arrow Articles by Grider, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Foxx-Orenstein, A. E.
Right arrow Articles by Grider, J. R.
Vol. 275, Issue 5, G979-G983, November 1998

5-HT4 receptor agonists and delta -opioid receptor antagonists act synergistically to stimulate colonic propulsion

A. E. Foxx-Orenstein, J.-G. Jin, and J. R. Grider

Departments of Medicine and Physiology, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298-0551

Opioid neurons exert a tonic restraint on inhibitory VIP/PACAP/NOS motoneurons of the enteric nervous system. A decrease in opioid peptide release during the descending phase of the peristaltic reflex, which underlies propulsive activity, leads to an increase in vasoactive intestinal peptide (VIP), pituitary adenylate cyclase-activating polypeptide (PACAP), and nitric oxide (NO) release and circular muscle relaxation. These effects are accentuated by opioid receptor antagonists. Endogenous opioid peptides and selective opioid delta -, kappa - and µ-receptor agonists decreased the velocity of pellet propulsion in isolated segments of guinea pig colon, whereas selective antagonists increased velocity in a concentration-dependent fashion with an order of potency indicating preferential involvement of delta -receptors. 5-HT4 agonists (HTF-919 and R-093877), which also increase the velocity of propulsion, acted synergistically with the delta -receptor antagonist naltrindole; a threshold concentration of naltrindole (10 nM) shifted the concentration-response curve to HTF-919 to the left by 70-fold. A combination of 10 nM naltrindole with threshold concentrations of the 5-HT4 agonists caused significant increases in the velocity of propulsion (50 ± 7 to 77 ± 8%). We conclude that 5-HT4 agonists and opioid delta -receptor antagonists act synergistically to facilitate propulsive activity in isolated colonic segments.

intestinal smooth muscle; enteric nervous system; gut motility


This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Liu, M. S. Geddis, Y. Wen, W. Setlik, and M. D. Gershon
Expression and function of 5-HT4 receptors in the mouse enteric nervous system
Am J Physiol Gastrointest Liver Physiol, December 1, 2005; 289(6): G1148 - G1163.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. L. Wells, J. L. Bartlett, S. Ananthan, and E. J. Bilsky
In Vivo Pharmacological Characterization of SoRI 9409, a Nonpeptidic Opioid {micro}-Agonist/delta -Antagonist That Produces Limited Antinociceptive Tolerance and Attenuates Morphine Physical Dependence
J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 597 - 605.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online